Legal & General Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $5.28K | Sell |
|
|||||
|
2024
Q4 | $82.3K | Hold |
|
|||||
|
2024
Q3 | $175K | Buy |
|
|||||
|
2024
Q2 | $19.3K | Buy |
|
|||||
|
2024
Q1 | $19.7K | Sell |
|
|||||
|
2023
Q4 | $17.1K | Sell |
|
|||||
|
2023
Q3 | $91.2K | Sell |
|
|||||
|
2023
Q2 | $238K | Buy |
|
|||||
|
2023
Q1 | $73K | Buy |
|
|||||
|
2022
Q4 | $50.9K | Hold |
|
|||||
|
2022
Q3 | $64K | Buy |
|
|||||
|
2022
Q2 | $35K | Buy |
|
|||||
|
2022
Q1 | $37K | Hold |
|
|||||
|
2021
Q4 | $69K | Hold |
|
|||||
|
2021
Q3 | $84K | Buy |
|
|||||
|
2021
Q2 | $28K | Buy |
|
|||||
|
2021
Q1 | $32K | Buy |
|
|||||
|
2020
Q4 | $17K | Hold |
|
|||||
|
2020
Q3 | $7K | Sell |
|
|||||
|
2020
Q2 | $14K | Sell |
|
|||||
|
2020
Q1 | $15K | Sell |
|
|||||
|
2019
Q4 | $71K | Buy |
|
|||||
|
2019
Q3 | $46K | Hold |
|
|||||
|
2019
Q2 | $98K | Hold |
|
|||||
|
2019
Q1 | $87K | Hold |
|
|||||
|
2018
Q4 | $103K | Buy |
|
|||||
|
2018
Q3 | $157K | Hold |
|
|||||
|
2018
Q2 | $176K | Sell |
|
|||||
|
2018
Q1 | $136K | Sell |
|
|||||
|
2017
Q4 | $197K | Hold |
|
|||||
|
2017
Q3 | $242K | Buy |
|
|||||
|
2017
Q2 | $305K | Buy |
|
|||||
|
2017
Q1 | $259K | Sell |
|
|||||
|
2016
Q4 | $252K | Buy |
|
|||||
|
2016
Q3 | $169K | Sell |
|
|||||
|
2016
Q2 | $144K | Hold |
|
|||||
|
2016
Q1 | $123K | Hold |
|
|||||
|
2015
Q4 | $135K | Hold |
|
|||||
|
2015
Q3 | $106K | Buy |
|
|||||
|
2015
Q2 | $53K | Sell |
|
|||||
|
2015
Q1 | $45K | Hold |
|
|||||
|
2014
Q4 | $41K | Hold |
|
|||||
|
2014
Q3 | $66K | Buy |
|